Unity Biotechnology, Inc. (LON: 0YC0)

Unity Biotechnology Statistics

Total Valuation

Unity Biotechnology has a market cap or net worth of GBP 28.59 million. The enterprise value is 24.85 million.

Market Cap	28.59M
Enterprise Value	24.85M

Important Dates

The next estimated earnings date is Thursday, March 13, 2025.

Earnings Date	Mar 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+15.08%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	14.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	2.71
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.52
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.45, with a Debt / Equity ratio of 1.73.

Current Ratio	3.45
Quick Ratio	3.31
Debt / Equity	1.73
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-28,260.79

Financial Efficiency

Return on equity (ROE) is -86.95% and return on invested capital (ROIC) is -34.44%.

Return on Equity (ROE)	-86.95%
Return on Assets (ROA)	-30.34%
Return on Capital (ROIC)	-34.44%
Revenue Per Employee	n/a
Profits Per Employee	-859,586
Employee Count	19
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.75% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+2.75%
50-Day Moving Average	1.34
200-Day Moving Average	1.57
Relative Strength Index (RSI)	64.81
Average Volume (20 Days)	7,496

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.50

Income Statement

Revenue	n/a
Gross Profit	-13.72M
Operating Income	-21.08M
Pretax Income	-16.33M
Net Income	-16.33M
EBITDA	-20.41M
EBIT	-21.08M
Earnings Per Share (EPS)	-0.99

Balance Sheet

The company has 21.66 million in cash and 18.23 million in debt, giving a net cash position of 3.44 million.

Cash & Cash Equivalents	21.66M
Total Debt	18.23M
Net Cash	3.44M
Net Cash Per Share	n/a
Equity (Book Value)	10.55M
Book Value Per Share	0.63
Working Capital	16.03M

Cash Flow

Operating Cash Flow	-16.81M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Unity Biotechnology does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.08%
Shareholder Yield	-15.08%
Earnings Yield	-57.12%
FCF Yield	n/a

Stock Splits

The last stock split was on October 20, 2022. It was a reverse split with a ratio of 0.1.

Last Split Date	Oct 20, 2022
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a